McMaster Textbook of Internal Medicine

McMaster Textbook of Internal Medicine
Lectures
Medical Grand Rounds
From neuroscience to artificial intelligence

From neuroscience to artificial intelligence

2022-06-29

Bryan Tripp, Mark Crowther

Dr Bryan Tripp from University of Waterloo shows how artificial intelligence learns from neuroscience and how clinical practitioners can benefit from understanding the logic behind neural networks. The webinar chaired by Dr Mark Crowther was recorded at the Chair's Medical Grand Rounds on April 7, 2022.

See also

Virtual care and remote monitoring after post-surgery discharge Dr P.J. Devereaux and Dr Michael McGillion discuss technology use in the postsurgical setting based on SMArTVIEW and PVC-RAM-1 trial results.
Reshaping research priorities to match massive crises Dr Kaveh G. Shojania from University of Toronto joins Dr Seychelle Yohanna to discuss the marginal effects of most efforts and biomedical research on health-care quality improvement.
Optimizing heart failure therapy in an ICD clinic Dr Aiman Alak from McMaster University joins Dr Khalid Azzam to review the role of optimal medical therapy in patients with heart failure with reduced ejection fraction (HFrEF).
Point-of-care testing: The path of the future Melanie McComb, point-of-care coordinator at Joseph Brant Hospital in Burlington, Ontario, discusses the advancements of point-of-care testing.
AI in medicine: Are there any risks? What do you consider the biggest dangers of artificial intelligence in medicine? With Dr Dan Perri.
Novel antiseizure drugs as first-line treatment Novel antiseizure drugs are typically approved as adjunctive therapy, to be used as an add-on. It might take years until their registration is expanded to include initial monotherapy. Do you think that cenobamate and other novel drugs could reduce the rates of drug resistance when introduced earlier, even as first-line medications in selected patients?
Chronic seizure management in patients with drug-resistant epilepsy We have a broad and still growing selection of antiseizure medications available, and yet drug resistance remains a challenge in roughly a third of patients with epilepsy. Why is this rate so high and how can we improve chronic seizure management in these patients?
Recent advances in neurology If you were to name the 3 most important recent advances in neurology that are relevant for everyday practice, what would they be?
Brain tumors: High-yield information Dr Navya Kalidindi from McMaster University provides a state-of-the-art update on the diagnosis and management of brain tumors.

We would love to hear from you

Comments, mistakes, suggestions?